Every story in this section, newest first — page 166 of 373.
Macy’s (NYSE:M) reported an increase in first-quarter profitability and sales, lifted by strong luxury performance at Bloomingdale’s and positive momentum across its core turnaround properties.
MiniMed (NASDAQ:MMED) reported a 15.6% increase in fourth-quarter net sales to $837 million, closing out a record-setting fiscal year 2026 driven by strong international adoption and rising attachment rates for its continuous glucose monitoring (CGM) technologies.
Medtronic (NYSE:MDT) reported a 9.9% increase in fourth-quarter revenue to $9.8 billion, closing out its fiscal year 2026 with broad-based operational momentum across its core therapeutic portfolios.
Miami International Holdings (NYSE:MIAX) reported sharp volume expansion across its options exchanges for May 2026, driven by an influx of retail and institutional derivatives trading that lifted the firm’s total market footprint.
Parsons (NYSE:PSN) has secured a new $28 million task order from the U.S. Air Force to provide advanced software lifecycle support and system integration, reinforcing its position as a key technology provider for national security initiatives.
Thor Industries (NYSE:THO) reported a drop in fiscal third-quarter profit and revenue, prompting the recreational vehicle manufacturer to lower its full-year earnings expectations.
MannKind (NASDAQ:MNKD) achieved key clinical development milestones for its investigational lung disease therapy, pushing its dry powder formulation of nintedanib further into mid-stage clinical testing.
KBR (NYSE:KBR) announced that its Mission Technology Solutions unit has been awarded a landmark $8 billion ceiling contract by the U.S. National Science Foundation (NSF) to provide comprehensive science and engineering support for the U.S. Antarctic Program.
T1 Energy (NYSE:TE) has entered into a definitive agreement to acquire KORE Power for an aggregate enterprise value of approximately $32 million, securing a specialized foothold in the rapidly expanding utility-scale energy storage sector.
IDEAYA Biosciences (NASDAQ:IDYA) has entered into a clinical collaboration agreement with Swiss healthcare giant Roche to evaluate a novel combination therapy aimed at a genetically distinct and difficult-to-treat form of pancreatic cancer.
Apple (NASDAQ:AAPL) has agreed to supply local financial data to India's antitrust regulator, dropping its long-standing refusal to do so as part of a high-stakes probe into its mobile app marketplace dominance.
Victoria’s Secret shares jumped about 50% in a single session - the best day in the company’s history - after earnings showed sales up 15%, profit nearly quadrupled and earnings per share roughly double Wall Street expectations.
Zhihu (NYSE:ZH) reported a sharp increase in adjusted profitability for the first quarter of 2026, overcoming a contraction in top-line revenue through disciplined operational efficiency and reduced overhead.
DBV Technologies (NASDAQ:DBVT) has screened the first participant in its THRIVE study, evaluating the Viaskin Peanut patch in infants aged 6 to 12 months over a multi-year period.
Zenas BioPharma (NASDAQ:ZBIO) reported positive late-stage clinical trial results for its experimental autoimmune therapy, hitting its primary and all key secondary targets in a study that could position the treatment as a new standard of care for a rare, debilitating inflammatory condition.
Figure Technology Solutions (NASDAQ:FIGR) released preliminary operating data for May 2026 on Wednesday, demonstrating significant year-over-year acceleration across its blockchain-native capital marketplace.
Johnson & Johnson (NYSE:JNJ) disclosed new data on Wednesday showing its experimental autoimmune treatment, nipocalimab, yields stronger clinical results in patients with higher concentrations of specific disease-driving biomarkers.
Johnson & Johnson’s (NYSE:JNJ) experimental therapy for systemic lupus erythematosus successfully met its primary objective in a mid-stage clinical trial.
argenx (NASDAQ:ARGX) reported new clinical data for its neonatal Fc receptor (FcRn) blocker, Vyvgart (efgartigimod), demonstrating durable therapeutic benefits and a highly consistent safety profile for patients living with myositis and Sjogren’s disease.
BW LPG (NYSE:BWLP) announced that it has completed the sale of its entire 8.50% equity stake in Confidence Petroleum India, marking the shipping firm's full exit as a shareholder in the Indian downstream LPG provider.
The Sherwin-Williams Company (NYSE:SHW) and Tokyo-based Nippon Paint Group have officially terminated their joint efforts to acquire AkzoNobel, bringing an end to a high-profile pursuit that threatened to reshape the global paints and coatings industry.
BP (NYSE:BP) is weighing a total departure from the UK North Sea after more than 60 years of operation, following an aggressive series of tax hikes by the Labour government that have drastically shifted the economic viability of mature oil and gas basins.
Meta Platforms (NASDAQ:META) scored a partial victory in its legal battle against sweeping European Union digital regulations on Wednesday, as Europe's second-highest court overturned an antitrust label applied to its Marketplace platform while upholding the same restrictions for its Messenger app.
Karyopharm Therapeutics (NASDAQ:KPTI) announced that its late-breaking Phase 3 SENTRY clinical trial data has been selected for an oral presentation at the European Hematology Association (EHA) 2026 Congress, placing the treatment among the top six late-breaking abstracts at the event.
